129 related articles for article (PubMed ID: 16725008)
21. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma].
Tan WL; Xiong L; Zheng SB; Yu ZC; Qi H; Du YJ; Wu P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1316-8. PubMed ID: 16982445
[TBL] [Abstract][Full Text] [Related]
23. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
24. High incidence of GalNAc disialosyl lactotetraosylceramide in metastatic renal cell carcinoma.
Maruyama R; Saito S; Bilim V; Hara N; Itoi T; Yamana K; Nishiyama T; Arai Y; Takahashi K; Tomita Y
Anticancer Res; 2007; 27(6C):4345-50. PubMed ID: 18214042
[TBL] [Abstract][Full Text] [Related]
25. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
[TBL] [Abstract][Full Text] [Related]
26. CD10 is a diagnostic and prognostic marker in renal malignancies.
Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
Histopathology; 2004 Nov; 45(5):460-7. PubMed ID: 15500649
[TBL] [Abstract][Full Text] [Related]
27. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.
Ito K; Yoshii H; Asakuma J; Sato A; Horiguchi A; Sumitomo M; Hayakawa M; Asano T
Jpn J Clin Oncol; 2009 Sep; 39(9):588-94. PubMed ID: 19556339
[TBL] [Abstract][Full Text] [Related]
30. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
[TBL] [Abstract][Full Text] [Related]
31. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant enzymes in renal cell carcinoma.
Soini Y; Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Tammela TL; Peltoniemi M; Martikainen PM; Kinnula LV
Histol Histopathol; 2006 Feb; 21(2):157-65. PubMed ID: 16329040
[TBL] [Abstract][Full Text] [Related]
33. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
34. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
Campbell L; Nuttall R; Griffiths D; Gumbleton M
Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
36. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
[TBL] [Abstract][Full Text] [Related]
37. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin D expression in renal cell cancer-clinical implications.
Merseburger AS; Hennenlotter J; Simon P; Ohneseit PA; Kuehs U; Kruck S; Koch E; Vogel U; Stenzl A; Kuczyk MA
Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.
Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
